Alexandria Real Estate Equities
ARE
#2318
Rank
โ‚น713.83 B
Marketcap
โ‚น4,130
Share price
-1.50%
Change (1 day)
-51.26%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -โ‚น2.25 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are โ‚น2.97 Billion. In 2024 the company made an earning of โ‚น62.85 Billion, an increase over its 2023 earnings that were of โ‚น32.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.25 Billion-103.58%
2024 โ‚น62.85 B96.11%
2023 โ‚น32.05 B-53.56%
2022 โ‚น69.01 B-3.96%
2021 โ‚น71.86 B-20.26%
2020 โ‚น90.12 B72.88%
2019 โ‚น52.12 B3.11%
2018 โ‚น50.55 B73.54%
2017 โ‚น29.13 B464.88%
2016 โ‚น5.15 B-77.32%
2015 โ‚น22.73 B36.31%
2014 โ‚น16.67 B-10.81%
2013 โ‚น18.70 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.069 T-57,124.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น892.03 B-47,665.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.030 T-108,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น89.78 B-4,887.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น724.83 B-38,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น743.87 B-39,765.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.75 B-727.01%๐Ÿ‡บ๐Ÿ‡ธ USA